GlassScriptPhysician profile
Bernard J Gottschalk
NPI 1629298872
$188,217.58
in general payments reported to CMS, 2019-2025
9 companies · $18K in 2025
The $18K reported for 2025 was more than what 98% of Addiction Medicine (Internal Medicine) providers received nationally (typical 2025 total: $124).
See the full distribution for Addiction Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56K · 2020: $20K · 2021: $35K · 2022: $28K · 2023: $18K · 2024: $13K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $36K · Travel and Lodging: $4,906 · Food and Beverage: $3,071 · Consulting Fee: $2,646 · Gift: $1,414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $36,449.50 |
| Travel and Lodging | $4,906.22 |
| Food and Beverage | $3,071.06 |
| Consulting Fee | $2,646.00 |
| Gift | $1,413.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $149,226.80 | 2019-2025 | Vivitrol, Vivitrol |
| Indivior INC. | $34,393.92 | 2019-2025 | Sublocade |
| Uswm, LLC | $3,585.90 | 2022-2024 | Zimhi, Lucemyra |
| Teva Pharmaceuticals USA, INC. | $607.16 | 2019-2022 | |
| Braeburn INC. | $200.95 | 2023-2025 | Brixadi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $127.03 | 2022 | |
| Abbvie INC. | $31.80 | 2024 | |
| Mdd US Operations, LLC | $30.92 | 2019 | |
| Zyla Life Sciences, INC. | $13.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bernard Gottschalk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.